Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine Pre-conditioning for Non-remission AML Transplant
NCT04002115Phase 2Terminated
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Jun 2020
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), sponsored by Penn State Health Milton S. Hershey Medical Center. Started Jun 2020; status: terminated.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT04002115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04002115.